Borisov A E, Gershanovich M L, Zemlianoĭ V P, Nepomniashchaia S L, Stukov A N, Filov V A
Medical Academy for Postgraduate Education, St. Petersburg.
Vopr Onkol. 1998;44(6):714-7.
An evaluation of the treatment of 42 patients with extended primary hepatic tumors and multiple intrahepatic metastases of colorectal carcinoma established the effectiveness of a newly-developed fat-soluble cytostatic drug--dioxadet, used for chemoembolization particularly, when foci fed from small arterial vessels were located along the periphery.
对42例患有原发性肝脏肿瘤扩展和结直肠癌多发肝内转移的患者进行的一项治疗评估，证实了一种新开发的脂溶性细胞抑制药物——二恶地特的有效性，该药物特别用于化学栓塞，尤其是当从小动脉血管供血的病灶位于周边时。
